A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against <i>Escherichia coli</i>.

Front Pharmacol · 2022 · PMC9521280 · PMID 36188537

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

1⁄4 MIC showed a poorer antibacterial effect compared to other concentrations, and the graph line showed an increasing trend with time.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.